2022-RA-807-ESGO MLH1 promoter methylation analysis in patients with endometrial cancer stage I-II | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Translational research/biomarkers

2022-RA-807-ESGO MLH1 promoter methylation analysis in patients with endometrial cancer stage I-II

Free

Online download statistics by month:

Online download statistics by month: October 2022 to October 2024

	Abstract	Full	Pdf
Oct 2022	90	0	15
Nov 2022	46	0	6
Dec 2022	43	0	14
Jan 2023	27	0	7
Feb 2023	25	0	3
Mar 2023	17	0	4
Apr 2023	35	0	5
May 2023	27	0	8
Jun 2023	8	0	2
Jul 2023	12	0	3
Aug 2023	21	0	3
Sep 2023	10	0	8
Oct 2023	22	0	4
Nov 2023	20	0	34
Dec 2023	23	0	35
Jan 2024	8	0	34
Feb 2024	10	0	30
Mar 2024	10	0	18
Apr 2024	18	0	4
May 2024	12	0	2
Jun 2024	8	0	6
Jul 2024	4	0	4
Aug 2024	5	0	7
Sep 2024	12	0	4
Oct 2024	8	0	0
Total	521	0	260